Role of cholesterol 24S-hydroxylase gene polymorphism (rs754203) in primary open angle glaucoma

Molecular Vision

Volumn 17, Issue , 2011, Pages 616-620

  Mossböck, Georg ^a   Weger, Martin ^a   Faschinger, Christoph ^a   Schmut, Otto ^a   Renner, Wilfried ^a   Wedrich, Andreas ^a   Zimmermann, Christina ^a   El Shabrawi, Yosuf ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

24 HYDROXYCHOLESTEROL; CHOLESTEROL DERIVATIVE; CYTOCHROME P450; CYTOCHROME P450 46A1; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PATHOGENESIS; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGED; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLAUCOMA, OPEN-ANGLE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; STEROID HYDROXYLASES;

EID: 79952178147     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82:844-51. [PMID: 15640920]
2. Kwon YH, Fingert JH, Kuehn MH, Alward WL. Primary openangle glaucoma. N Engl J Med 2009; 360:1113-24. [PMID:19279343]
3. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Family history and risk of primary open angle glaucoma. The Baltimore Eye Survey. Arch Ophthalmol 1994; 112:69-73. [PMID: 8285897]
4. Wolfs RC, Klaver CC, Ramrattan RS, van Duijn CM, Hofman A, de Jong PT. Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study. Arch Ophthalmol 1998; 116:1640-5. [PMID: 9869795]
5. Allingham RR, Liu Y, Rhee DJ. The genetics of primary openangle glaucoma: a review. Exp Eye Res 2009; 88:837-44. [PMID: 19061886]
6. Mossböck G, Faschinger C, Weger M, Renner W. Role of genetic factors in glaucomas. Spektrum Augenheilkd 2008; 22:227-32.
7. McGwin G Jr, McNeal S, Owsley C, Girkin C, Epstein D, Lee PP. Statins and other cholesterol-lowering medications and the presence of glaucoma. Arch Ophthalmol 2004; 122:822-6. [PMID: 15197056]
8. Leung DY, Li FC, Kwong YY, Tham CC, Chi SC, Lam DS. Simvastatin and Disease Stabilization in Normal Tension Glaucoma: A Cohort Study. Ophthalmology 2010; 117:471-6. [PMID: 20045568]
9. De Castro DK, Punjabi OS, Bostrom AG, Stamper RL, Lietman TM, Ray K, Lin SC. Effect of statin drugs and aspirin on progression in open-angle glaucoma suspects using confocal scanning laser ophthalmoscopy. Clin Experiment Ophthalmol 2007; 35:506-13. [PMID: 17760631]
10. Leoni V. Oxysterols as markers of neurological disease - a review. Scand J Clin Lab Invest 2009; 69:22-5. [PMID:19199127]
11. Björkhem I, Lütjohann D, Diczfalusy U, Ståhle L, Ahlborg G, Wahren J. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res 1998; 39:1594-600. [PMID: 9717719]
12. Bretillon L, Diczfalusy U, Björkhem I, Maire MA, Martine L, Joffre C, Acar N, Bron A, Creuzot-Garcher C. Cholesterol-24S-hydroxylase (CYP46A1) is specifically expressed in neurons of the neural retina. Curr Eye Res 2007; 32:361-6. [PMID: 17453958]
13. Ramirez DM, Andersson S, Russell DW. Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain. J Comp Neurol 2008; 507:1676-93. [PMID:18241055]
14. Yücel I, Akar Y, Yücel G, Ciftçioǧlu MA, Keleş N, Aslan M. Effect of hypercholesterolemia on inducible nitric oxide synthase expression in a rat model of elevated intraocular pressure. Vision Res 2005; 45:1107-14. [PMID: 15707919]
15. Kölsch H, Lütjohann D, Tulke A, Björkhem I, Rao ML. The neurotoxic effect of 24-hydroxycholesterol on SH-SY5Y human neuroblastoma cells. Brain Res 1999; 818:171-5. [PMID: 9914453]
16. Fourgeux C, Martine L, Björkhem I, Diczfalusy U, Joffre C, Acar N, Creuzot-Garcher C, Bron A, Bretillon L. Primary open-angle glaucoma: association with cholesterol 24Shydroxylase (CYP46A1) gene polymorphism and plasma 24- hydroxycholesterol levels. Invest Ophthalmol Vis Sci 2009; 50:5712-7. [PMID: 19553612]
17. Hoddap E, Parrish R, Anderson D. Clinical decisions in glaucoma. Saint Louis (MO): Mosby Year Book; 1993.
18. Dupont WD, Plummer WD. PS power and sample size program available for free on the Internet. Control Clin Trials 1997; 18:274.
19. Papassotiropoulos A, Streffer JR, Tsolaki M, Schmid S, Thal D, Nicosia F, Iakovidou V, Maddalena A, Lütjohann D, Ghebremedhin E, Hegi T, Pasch T, Träxler M, Brühl A, Benussi L, Binetti G, Braak H, Nitsch RM, Hock C. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neurol 2003; 60:29-35. [PMID:12533085]
20. Golanska E, Hulas-Bigoszewska K, Wojcik I, Rieske P, Styczynska M, Peplonska B, Pfeffer A, Luczywek E, Wasiak B, Gabryelewicz T, Religa D, Chodakowska-Zebrowska M, Barcikowska M, Sobow T, Liberski PP. CYP46: a risk factor for Alzheimer's disease or a coincidence? Neurosci Lett 2005; 383:105-8. [PMID: 15936520]
21. Garcia AN, Muniz MT, Souza e Silva HR, da Silva HA, Athayde-Junior L. Cyp46 polymorphisms in Alzheimer's disease: a review. J Mol Neurosci 2009; 39:342-5. [PMID:19705089]
22. Wang B, Zhang C, Zheng W, Lu Z, Zheng C, Yang Z, Wang L, Jin F. Association between a T/C polymorphism in intron 2 of cholesterol 24S-hydroxylase gene and Alzheimer's disease in Chinese. Neurosci Lett 2004; 369:104-7. [PMID:15450677]
23. Fernández Del Pozo V, Alvarez Alvarez M, Fernández Martínez M, Galdós Alcelay L, Gómez Busto F, Peña JA, Alfonso-Sánchez MA, Zarranz Imirizaldu JJ, de Pancorbo MM. Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APOEpsilon3 allele increases the risk of Alzheimer's disease and of mild cognitive impairment progressing to Alzheimer's disease. Dement Geriatr Cogn Disord 2006; 21:81-7. [PMID: 16340204]
24. Borroni B, Archetti S, Agosti C, Akkawi N, Brambilla C, Caimi L, Caltagirone C, Di Luca M, Padovani A. Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators. Neurobiol Aging 2004; 25:747-51. [PMID: 15165699]
25. Kölsch H, Lütjohann D, Ludwig M, Schulte A, Ptok U, Jessen F, von Bergmann K, Rao ML, Maier W, Heun R. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease. Mol Psychiatry 2002; 7:899-902. [PMID: 12232784]
26. Combarros O, Infante J, Llorca J, Berciano J. Genetic association of CYP46 and risk for Alzheimer's disease. Dement Geriatr Cogn Disord 2004; 18:257-60. [PMID:15286456]
27. Li Y, Chu LW, Chen YQ, Cheung BM, Leung RY, Yik PY, Ng KM, Mak W, Jin DY, St George-Hyslop P, Song YQ. Intron 2 (T/C) CYP46 polymorphism is associated with Alzheimer's disease in Chinese patients. Dement Geriatr Cogn Disord 2006; 22:399-404. [PMID: 16960449]
28. Jensen CJ, Oldfield BJ, Rubio JP. Splicing, cis genetic variation and disease. Biochem Soc Trans 2009; 37:1311-5. [PMID: 19909267]
29. Sjögren M, Andreasen N, Blennow K. Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers. Clin Chim Acta 2003; 332:1-10. [PMID: 12763273]
30. Yoneda S, Hara H, Hirata A, Fukushima M, Inomata Y, Tanihara H. Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases. Jpn J Ophthalmol 2005; 49:106-8. [PMID: 15838725]